Answer
The mean elimination half-life of ertugliflozin in patients with type 2 diabetes and normal renal function was estimated at 17 hours based on population pharmacokinetic analysis.
Sources for this answer
- Steglatro 5 mg and 15 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 9Document updated
Sources checked